<?xml version="1.0" encoding="UTF-8"?>
<table-wrap position="float" id="t0015">
 <label>Table 2</label>
 <caption>
  <p>RSV vaccines in development, by vaccine type, phase of development and target population. Number of vaccine products in development is shown in parenthesis.</p>
 </caption>
 <alt-text id="al0020">Table 2</alt-text>
 <table frame="hsides" rules="groups">
  <thead>
   <tr>
    <th>RSV vaccine type</th>
    <th>Preclinical</th>
    <th>Clinical phase I</th>
    <th>Clinical phase II</th>
    <th>Clinical phase III</th>
   </tr>
  </thead>
  <tbody>
   <tr>
    <td>Live attenuated/Chimeric</td>
    <td>RSV (3)
     <break/>RSV/PIV-1-3 (1)
    </td>
    <td>RSV-ΔG
     <break/>(1) Pediatric
     <break/>RSV ΔNS2/Δ1313/I11314L
     <break/>(1) Pediatric
     <break/>RSV 6120/ΔNS2/1030s
     <break/>(1) Pediatric
     <break/>RSV Δ46/NS2/N/ΔM2-2-
     <italic>Hin</italic>dIII
     <break/>(1) Pediatric
     <break/>SeV/RSV
     <break/>(1) Pediatric
     <break/>BCG/RSV
     <break/>(1) Pediatric
    </td>
    <td>–</td>
    <td>–</td>
   </tr>
   <tr>
    <td>Whole virus inactivated</td>
    <td>RSV (1)</td>
    <td>–</td>
    <td>–</td>
    <td>–</td>
   </tr>
   <tr>
    <td>Particle based</td>
    <td>VLP (7)
     <break/>Peptide microparticle (1)
    </td>
    <td>RSF F Nanoparticle
     <break/>(1) Pediatric
    </td>
    <td>RSV F Nanoparticle (1) Elderly</td>
    <td>RSV F Nanoparticle (1) 
     <bold>Maternal</bold>
     <xref rid="tf0010" ref-type="table-fn">﻿a﻿</xref>
    </td>
   </tr>
   <tr>
    <td>Subunit</td>
    <td>RSV F-protein (2)
     <break/>RSV G-protein (2)
    </td>
    <td>RSV F-protein
     <break/>(2) 
     <bold>Maternal</bold>
     <xref rid="tf0015" ref-type="table-fn">﻿b﻿</xref>
     <break/>(3) Elderly
     <break/>RSV G-protein
     <break/>(1) Pediatric and Elderly
     <break/>DPX-RSV-SM Protein
     <break/>(1) Elderly
    </td>
    <td>RSV F-Protein (1) 
     <bold>Maternal</bold>
     <xref rid="tf0020" ref-type="table-fn">﻿c﻿</xref> and Elderly
    </td>
    <td>–</td>
   </tr>
   <tr>
    <td>Nucleic acid</td>
    <td>RNA (1)
     <break/>DNA (1)
    </td>
    <td>–</td>
    <td>–</td>
    <td>–</td>
   </tr>
   <tr>
    <td>Recombinant vector</td>
    <td>Adenovirus (1)</td>
    <td>Adenovirus
     <break/>(1) Elderly
    </td>
    <td>Adenovirus
     <break/>(2) Pediatric
     <break/>(1) Elderly
     <break/>MVA
     <break/>(1) Elderly
    </td>
    <td>–</td>
   </tr>
  </tbody>
 </table>
 <table-wrap-foot>
  <fn>
   <p>Bold highlights represent maternal vaccines.</p>
  </fn>
 </table-wrap-foot>
 <table-wrap-foot>
  <fn id="tf0010">
   <label>a</label>
   <p id="np0010">RSV F nanoparticle (Novavax, Rockville, MD) Post-F “prefusogenic”, adjuvanted with ALPO
    <sub>4</sub> or Matrix M.
   </p>
  </fn>
 </table-wrap-foot>
 <table-wrap-foot>
  <fn id="tf0015">
   <label>b</label>
   <p id="np0015">DS-Cav 1 (NIH) Pre-F subunit, Alum adjuvanted vaccine and GSK RSV F (GlaxoSmithKline, Brentford, UK) Pre-F with and without adjuvant.</p>
  </fn>
 </table-wrap-foot>
 <table-wrap-foot>
  <fn id="tf0020">
   <label>c</label>
   <p id="np0020">RSV F (Pfizer, New York, NY), Pre-F with and without adjuvant.</p>
  </fn>
 </table-wrap-foot>
 <attrib>Source: Adapted from PATH 
  <ext-link ext-link-type="uri" xlink:href="https://www.path.org/resources/rsv-vaccine-and-mab-snapshot/" id="ir0010" xmlns:xlink="http://www.w3.org/1999/xlink">https://www.path.org/resources/rsv-vaccine-and-mab-snapshot/</ext-link>.
 </attrib>
</table-wrap>
